Cargando…

2-methylquinazoline derivative F7 as a potent and selective HDAC6 inhibitor protected against rhabdomyolysis-induced acute kidney injury

Histone deacetylases 6 (HDAC6) has been reported to be involved in the pathogenesis of rhabdomyolysis-induced acute kidney injury (AKI). Selective inhibition of HDAC6 activity might be a potential treatment for AKI. In our lab, N-hydroxy-6-(4-(methyl(2-methylquinazolin-4-yl)amino)phenoxy)nicotinamid...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jing, Cui, Xue, Guo, Fan, Li, Xinrui, Li, Lingzhi, Pan, Jing, Tao, Sibei, Huang, Rongshuang, Feng, Yanhuan, Ma, Liang, Fu, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804997/
https://www.ncbi.nlm.nih.gov/pubmed/31639165
http://dx.doi.org/10.1371/journal.pone.0224158
_version_ 1783461303735549952
author Liu, Jing
Cui, Xue
Guo, Fan
Li, Xinrui
Li, Lingzhi
Pan, Jing
Tao, Sibei
Huang, Rongshuang
Feng, Yanhuan
Ma, Liang
Fu, Ping
author_facet Liu, Jing
Cui, Xue
Guo, Fan
Li, Xinrui
Li, Lingzhi
Pan, Jing
Tao, Sibei
Huang, Rongshuang
Feng, Yanhuan
Ma, Liang
Fu, Ping
author_sort Liu, Jing
collection PubMed
description Histone deacetylases 6 (HDAC6) has been reported to be involved in the pathogenesis of rhabdomyolysis-induced acute kidney injury (AKI). Selective inhibition of HDAC6 activity might be a potential treatment for AKI. In our lab, N-hydroxy-6-(4-(methyl(2-methylquinazolin-4-yl)amino)phenoxy)nicotinamide (F7) has been synthesized and inhibited HDAC6 activity with the IC(50) of 5.8 nM. However, whether F7 possessed favorable renoprotection against rhabdomyolysis-induced AKI and the involved mechanisms remained unclear. In the study, glycerol-injected mice developed severe AKI symptoms as indicated by acute renal dysfunction and pathological changes, accompanied by the overexpression of HDAC6 in tubular epithelial cells. Pretreatment with F7 at a dose of 40 mg/kg/d for 3 days significantly attenuated serum creatinine, serum urea, renal tubular damage and suppressed renal inflammatory responses. Mechanistically, F7 enhanced the acetylation of histone H3 and α-tubulin to reduce HDAC6 activity. Glycerol-induced AKI triggered multiple signal mediators of NF-κB pathway as well as the elevation of ERK1/2 protein and p38 phosphorylation. Glycerol also induced the high expression of proinflammatory cytokine IL-1β and IL-6 in kidney and human renal proximal tubule HK-2 cells. Treatment of F7 notably improved above-mentioned inflammatory responses in the injured kidney tissue and HK-2 cell. Overall, these data highlighted that 2-methylquinazoline derivative F7 inhibited renal HDAC6 activity and inflammatory responses to protect against rhabdomyolysis-induced AKI.
format Online
Article
Text
id pubmed-6804997
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-68049972019-11-02 2-methylquinazoline derivative F7 as a potent and selective HDAC6 inhibitor protected against rhabdomyolysis-induced acute kidney injury Liu, Jing Cui, Xue Guo, Fan Li, Xinrui Li, Lingzhi Pan, Jing Tao, Sibei Huang, Rongshuang Feng, Yanhuan Ma, Liang Fu, Ping PLoS One Research Article Histone deacetylases 6 (HDAC6) has been reported to be involved in the pathogenesis of rhabdomyolysis-induced acute kidney injury (AKI). Selective inhibition of HDAC6 activity might be a potential treatment for AKI. In our lab, N-hydroxy-6-(4-(methyl(2-methylquinazolin-4-yl)amino)phenoxy)nicotinamide (F7) has been synthesized and inhibited HDAC6 activity with the IC(50) of 5.8 nM. However, whether F7 possessed favorable renoprotection against rhabdomyolysis-induced AKI and the involved mechanisms remained unclear. In the study, glycerol-injected mice developed severe AKI symptoms as indicated by acute renal dysfunction and pathological changes, accompanied by the overexpression of HDAC6 in tubular epithelial cells. Pretreatment with F7 at a dose of 40 mg/kg/d for 3 days significantly attenuated serum creatinine, serum urea, renal tubular damage and suppressed renal inflammatory responses. Mechanistically, F7 enhanced the acetylation of histone H3 and α-tubulin to reduce HDAC6 activity. Glycerol-induced AKI triggered multiple signal mediators of NF-κB pathway as well as the elevation of ERK1/2 protein and p38 phosphorylation. Glycerol also induced the high expression of proinflammatory cytokine IL-1β and IL-6 in kidney and human renal proximal tubule HK-2 cells. Treatment of F7 notably improved above-mentioned inflammatory responses in the injured kidney tissue and HK-2 cell. Overall, these data highlighted that 2-methylquinazoline derivative F7 inhibited renal HDAC6 activity and inflammatory responses to protect against rhabdomyolysis-induced AKI. Public Library of Science 2019-10-22 /pmc/articles/PMC6804997/ /pubmed/31639165 http://dx.doi.org/10.1371/journal.pone.0224158 Text en © 2019 Liu et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Liu, Jing
Cui, Xue
Guo, Fan
Li, Xinrui
Li, Lingzhi
Pan, Jing
Tao, Sibei
Huang, Rongshuang
Feng, Yanhuan
Ma, Liang
Fu, Ping
2-methylquinazoline derivative F7 as a potent and selective HDAC6 inhibitor protected against rhabdomyolysis-induced acute kidney injury
title 2-methylquinazoline derivative F7 as a potent and selective HDAC6 inhibitor protected against rhabdomyolysis-induced acute kidney injury
title_full 2-methylquinazoline derivative F7 as a potent and selective HDAC6 inhibitor protected against rhabdomyolysis-induced acute kidney injury
title_fullStr 2-methylquinazoline derivative F7 as a potent and selective HDAC6 inhibitor protected against rhabdomyolysis-induced acute kidney injury
title_full_unstemmed 2-methylquinazoline derivative F7 as a potent and selective HDAC6 inhibitor protected against rhabdomyolysis-induced acute kidney injury
title_short 2-methylquinazoline derivative F7 as a potent and selective HDAC6 inhibitor protected against rhabdomyolysis-induced acute kidney injury
title_sort 2-methylquinazoline derivative f7 as a potent and selective hdac6 inhibitor protected against rhabdomyolysis-induced acute kidney injury
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804997/
https://www.ncbi.nlm.nih.gov/pubmed/31639165
http://dx.doi.org/10.1371/journal.pone.0224158
work_keys_str_mv AT liujing 2methylquinazolinederivativef7asapotentandselectivehdac6inhibitorprotectedagainstrhabdomyolysisinducedacutekidneyinjury
AT cuixue 2methylquinazolinederivativef7asapotentandselectivehdac6inhibitorprotectedagainstrhabdomyolysisinducedacutekidneyinjury
AT guofan 2methylquinazolinederivativef7asapotentandselectivehdac6inhibitorprotectedagainstrhabdomyolysisinducedacutekidneyinjury
AT lixinrui 2methylquinazolinederivativef7asapotentandselectivehdac6inhibitorprotectedagainstrhabdomyolysisinducedacutekidneyinjury
AT lilingzhi 2methylquinazolinederivativef7asapotentandselectivehdac6inhibitorprotectedagainstrhabdomyolysisinducedacutekidneyinjury
AT panjing 2methylquinazolinederivativef7asapotentandselectivehdac6inhibitorprotectedagainstrhabdomyolysisinducedacutekidneyinjury
AT taosibei 2methylquinazolinederivativef7asapotentandselectivehdac6inhibitorprotectedagainstrhabdomyolysisinducedacutekidneyinjury
AT huangrongshuang 2methylquinazolinederivativef7asapotentandselectivehdac6inhibitorprotectedagainstrhabdomyolysisinducedacutekidneyinjury
AT fengyanhuan 2methylquinazolinederivativef7asapotentandselectivehdac6inhibitorprotectedagainstrhabdomyolysisinducedacutekidneyinjury
AT maliang 2methylquinazolinederivativef7asapotentandselectivehdac6inhibitorprotectedagainstrhabdomyolysisinducedacutekidneyinjury
AT fuping 2methylquinazolinederivativef7asapotentandselectivehdac6inhibitorprotectedagainstrhabdomyolysisinducedacutekidneyinjury